Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 9Stomach Neoplasms 1Pancreatic Neoplasms 1Nephrotic Syndrome 1Neoplasm Metastasis 1Kidney Diseases 1Hepatitis B 1Gastrointestinal Diseases 1Familial Mediterranean Fever 1Esophageal Neoplasms 1Colorectal Adenocarcinoma 1Cholangiocarcinoma 1BRAF V600 Colorectal Cancer 1Arthritis, Rheumatoid 1Amyloidosis 1Adenomatous Polyposis Coli 1

Interventions

Celecoxib 7Biopsy 5Sulindac 4Specimen Handling 3Eflornithine 3Curcumin 3guselkumab 2Ursodeoxycholic Acid 2Surveys and Questionnaires 2Sirolimus 2Sigmoidoscopy 2Gastroscopy 2Erythromycin 2Erlotinib Hydrochloride 2Endoscopy, Gastrointestinal 2Endoscopy, Digestive System 2Endoscopy 2Colonoscopy 2trifluridine tipiracil drug combination 1rofecoxib 1obeticholic acid 1Thiamine 1Surgical Procedures, Operative 1Suppositories 1Probiotics 1Polymorphism, Single-Stranded Conformational 1Polymerase Chain Reaction 1Pharmaceutical Preparations 1Oxaliplatin 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenomatous Polyposis Coli × Pharmaceutical Preparations × Gastrointestinal × Clear all
NCT00319007 2007-08-10

Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis

Radboud University Medical Center

Phase 2 Unknown
30 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡